To date no study has found a link with VDR polymorphisms and airway infection in COPD although there are several mechanisms by which activated 25-hydroxyvitamin D binding to the VDR could modulate viral lower respiratory tract disease [41-43]. This evidence concerns the gene VDR and lower respiratory tract disorder.